16 – 18 November 2021

OneRoche Days Webinar

00
Days
00
Hours
00
Minutes
00
Seconds
14.00 - 14.15 CET
The Pregnancy Journey

The Pregnancy Journey

Sraboni Sarkar

The Pregnancy Journey - this presentation will focus on two important topics AMH Plus fertility test & PlGF/sFlT Preeclampsia tests.

14.15 - 14.30 CET
In a frontline with Preeclampsia

In a frontline with Preeclampsia

Suzana Drobnjak

The main objective of the presentation will be to share clinical experience on pre-eclampsia and the importance of using SFLT-1 and PLGF biomarkers.

14.30 - 14.45 CET
Astraia SW - doctor's experience

Astraia SW - doctor's experience

Viktoria Badiuk

Healthy life begins in the womb! Astraia software is a tool that supports the diagnosis of pregnant women.

14.45 - 15.00 CET
Vit D - doctor's experience

Vit D - doctor's experience

Nataliya Balatska

Vitamin D has a number of benefits. It protects teeth and bones and guards against disease. Join us to learn about the clinical significance of vitamin D deficiency and treatment options.

14:30 - 15:00 CET
Cardiovascular risk assessment for patients with type 2 diabetes

Cardiovascular risk assessment for patients with type 2 diabetes

Piotr Rozentryt

People with T2D are automatically at high risk of cardiovascular diseases due to the strong association between these conditions. The aim of that presentation is to have a closer look at the CVD risk assessment for patients with type 2 diabetes.

15:00 CET

Q&A

14:00 - 14:20 CET
Role of viruses in the context of hepatitis

Role of viruses in the context of hepatitis

Peter Ramge

Hepatitis viruses are the most common cause of hepatitis in the world. The role of diagnostics is extremely important, therefore, Roche constantly evaluates and improves the ID pipeline.

14:20 - 15:00 CET
Road to HCV elimination

Road to HCV elimination

Jerzy Jaroszewicz

Polish experience with HCV elimination and possible pitfalls during the implementation of strategies.

15:00 - 15:25 CET
Roche Integrated Infectious Disease Laboratory

Roche Integrated Infectious Disease Laboratory

Hans-Joachim Degen

A reliable solution is needed to fulfill challenging diagnostic environment. Roche understands that and offers an integrated infectious disease portfolio to meet customer expectations

15.25 - 15.50 CET
Biomarkers of HCC Surveillance and Early Detection

Biomarkers of HCC Surveillance and Early Detection

Daniel Cigoianu

One of the challenges in oncology is the identification of patients at high risk and catch the disease as fast as possible. Biomarkers can be an aid in surveillance and diagnosis for a disease often diagnosed too late and HCC is one of the examples.

LISTEN TO THE Event Speakers

Jerzy Jaroszewicz

Associate Professor, Head of Department of Infectious Diseases and Hepatology of Medical University of Silesia, Katowice, Poland

Viktoria Badiuk

Chief of Laboratory Department, PhD - Reproductive Genetics Clinic “Victoria”

Nataliya Balatska

Associate Professor, MD, at Kiev Medical University of UAFM

Piotr Pruszczyk

Vice Chancellor for Science and Technology Transfer, Medical University of Warsaw